Inventor · Carlsbad, CA, US

Ying Buechler

17Patents
11h-index
22Co-inventors
68Inventor score

Filing activity: Dec 21, 2005 → Apr 7, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US7816320B2 Formulations of human growth hormone comprising a non-naturally encoded amino acid at position 35 Human Necessities 30 Active
US8178108B2 Methods for expression and purification of recombinant human growth hormone Human Necessities 29 Active
US9587235B2 Histidyl-tRNA synthetase-Fc conjugates Chemistry; Metallurgy 27 Active
US9688978B2 Aspartyl-tRNA synthetase-Fc conjugates Emerging Cross-Sectional Technologies 23 Active
US7959926B2 Methods for expression and purification of recombinant human growth hormone mutants Human Necessities 21 Active
US7947473B2 Methods for expression and purification of pegylated recombinant human growth hormone containing a non-naturally encoded keto amino acid Human Necessities 19 Active
US8178494B2 Modified human growth hormone formulations with an increased serum half-life Human Necessities 18 Active
US8163695B2 Formulations of human growth hormone comprising a non-naturally encoded amino acid Human Necessities 17 Active
US8080391B2 Process of producing non-naturally encoded amino acid containing high conjugated to a water soluble polymer Human Necessities 17 Expired
US10093915B2 Histidyl-tRNA synthetase-Fc conjugates Chemistry; Metallurgy 16 Active
US11072787B2 Histidyl-tRNA synthetase-Fc conjugates Chemistry; Metallurgy 13 Active
US10472618B2 Histidyl-tRNA synthetase-Fc conjugates Chemistry; Metallurgy 10 Active
US10711260B2 Histidyl-tRNA synthetase-Fc conjugates Chemistry; Metallurgy 9 Active
US9488660B2 Methods and compositions comprising non-natural amino acids Physics 3 Active
US9822353B2 PEGylated aspartyl-tRNA synthetase polypeptides Emerging Cross-Sectional Technologies 2 Active
US9714419B2 PEGylated tyrosyl-tRNA synthetase polypeptides Human Necessities 0 Active
US9816084B2 Aspartyl-tRNA synthetases Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.